Publication:
Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids

Thumbnail Image

Date

2017

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

Frontiers Media S.A.
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Ngwa, Wilfred, Rajiv Kumar, Michele Moreau, Raymond Dabney, and Allen Herman. 2017. “Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids.” Frontiers in Oncology 7 (1): 208. doi:10.3389/fonc.2017.00208. http://dx.doi.org/10.3389/fonc.2017.00208.

Research Data

Abstract

Nanotechnology has opened up a new, previously unimaginable world in cancer diagnosis and therapy, leading to the emergence of cancer nanomedicine and nanoparticle-aided radiotherapy. Smart nanomaterials (nanoparticle drones) can now be constructed with capability to precisely target cancer cells and be remotely activated with radiation to emit micrometer-range missile-like electrons to destroy the tumor cells. These nanoparticle drones can also be programmed to deliver therapeutic payloads to tumor sites to achieve optimal therapeutic efficacy. In this article, we examine the state-of-the-art and potential of nanoparticle drones in targeting lung cancer. Inhalation (INH) (air) versus traditional intravenous (“sea”) routes of navigating physiological barriers using such drones is assessed. Results and analysis suggest that INH route may offer more promise for targeting tumor cells with radiosensitizers and cannabinoids from the perspective of maximizing damage to lung tumors cells while minimizing any collateral damage or side effects.

Description

Keywords

Perspective, smart nanoparticles (drones), radiotherapy, radiosensitizers, cannabinoids, inhalation, intravenous delivery, lung cancer, therapeutic efficacy

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories